Preliminary immunologic observations of intratumoral EmT4™, a TLR4 agonist, in a canine soft tissue sarcoma
Open Access
- 1 August 2026
- journal article
- case report
- Published by Springer Nature in Veterinary Oncology
- Vol. 3 (1) , 17
Abstract
No abstract availableKeywords
Funding Information
- Canine Cancer Alliance
This publication has 51 references indexed in Scilit:
- Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumorMolecular and Cellular Biochemistry, 2024
- Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue SarcomaJAMA Oncology, 2023
- Paradoxical cancer cell stimulation by IFNγ drives tumor hyperprogression upon checkpoint blockade immunotherapyCancer Cell, 2023
- RNA in situ hybridisation as a molecular diagnostic technique targeting IBA‐1 and CD204 in canine histiocytic sarcomaVeterinary Medicine and Science, 2022
- Detection of SARS-CoV-2 by RNAscope® in situ hybridization and immunohistochemistry techniquesArchives of Virology, 2020
- The science of vaccine adjuvants: advances in TLR4 ligand adjuvantsCurrent Opinion in Immunology, 2016
- Comparison of Alpha-Synuclein Immunoreactivity in the Hippocampus Between the Adult and Aged Beagle DogsCellular and Molecular Neurobiology, 2012
- RNAscopeThe Journal of Molecular Diagnostics, 2012
- Safety Evaluation of Monophosphoryl Lipid A (MPL): An Immunostimulatory AdjuvantRegulatory Toxicology and Pharmacology, 2002
- Monophosphoryl Lipid A Induces Delayed Preconditioning Against Cardiac Ischemia-Reperfusion InjuryJournal of Molecular and Cellular Cardiology, 1998